Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy.

MLA

Dupuis, L.Lee, et al. “Risk Factors for Chemotherapy-Induced Nausea in Pediatric Patients Receiving Highly Emetogenic Chemotherapy.” Pediatric Blood & Cancer, vol. 66, no. 4, Apr. 2019, p. e27584. EBSCOhost, https://doi.org/10.1002/pbc.27584.

APA

Dupuis, L. L., Tamura, R. N., Kelly, K. M., Krischer, J. P., Langevin, A.-M., Chen, L., Kolb, E. A., Ullrich, N. J., Sahler, O. J. Z., Hendershot, E., Stratton, A., Sung, L., & McLean, T. W. (2019). Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy. Pediatric Blood & Cancer, 66(4), e27584. https://doi.org/10.1002/pbc.27584

Chicago

Dupuis, L Lee, Roy N Tamura, Kara M Kelly, Jeffrey P Krischer, Anne-Marie Langevin, Lu Chen, E Anders Kolb, et al. 2019. “Risk Factors for Chemotherapy-Induced Nausea in Pediatric Patients Receiving Highly Emetogenic Chemotherapy.” Pediatric Blood & Cancer 66 (4): e27584. doi:10.1002/pbc.27584.